Plante Moran Financial Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Plante Moran Financial Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,911	Closed	-$25.1K	–	866
2022 Q4	$95.2K	Hold	7,911	–	–	0.01%	235
2022 Q3	$51K	Hold	7,911	–	–	0.01%	301
2022 Q2	$36K	Buy	7,911 +331	+4%	+$1.77K	0.01%	359
2022 Q1	$66K	Hold	7,580	–	–	0.01%	288
2021 Q4	$108K	Hold	7,580	–	–	0.02%	240
2021 Q3	$167K	Hold	7,580	–	–	0.04%	211
2021 Q2	$101K	Buy	+7,580	New	+$86.7K	0.02%	247
2017 Q4	–	Sell	-300	Closed	-$3K	–	907
2017 Q3	$3K	Hold	300	–	–	﹤0.01%	704
2017 Q2	$2K	Hold	300	–	–	﹤0.01%	752
2017 Q1	$2K	Hold	300	–	–	﹤0.01%	799
2016 Q4	$2K	Hold	300	–	–	﹤0.01%	861
2016 Q3	$2K	Hold	300	–	–	﹤0.01%	845
2016 Q2	$3K	Hold	300	–	–	﹤0.01%	734
2016 Q1	$2K	Hold	300	–	–	﹤0.01%	738
2015 Q4	$3K	Hold	300	–	–	﹤0.01%	826
2015 Q3	$2K	Hold	300	–	–	﹤0.01%	663
2015 Q2	$2K	Hold	300	–	–	﹤0.01%	683
2015 Q1	$2K	Hold	300	–	–	﹤0.01%	673
2014 Q4	$1K	Hold	300	–	–	﹤0.01%	787
2014 Q3	$2K	Hold	300	–	–	﹤0.01%	748
2014 Q2	$3K	Hold	300	–	–	﹤0.01%	729
2014 Q1	$4K	Buy	+300	New	+$5.06K	﹤0.01%	500

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SIGI

Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Plante Moran Financial Advisors's ORMP Position: Q1 2023 in Review

Plante Moran Financial Advisors sold out of Oramed Pharmaceuticals (ORMP) in Q1 2023, closing a stake of 7,911 shares — an estimated $25.1K sold.

Plante Moran Financial Advisors first reported a position in ORMP in Q1 2014 and held it in 22 quarters. The position peaked at $167K in Q3 2021. 61 funds tracked by Wall St. Rank hold ORMP as of Q1 2023.

Plante Moran Financial Advisors reported no remaining Oramed Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Plante Moran Financial Advisors sold 7,911 Oramed Pharmaceuticals shares in Q1 2023, an estimated $25.1K.
Plante Moran Financial Advisors first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 22 quarters.
Plante Moran Financial Advisors's Oramed Pharmaceuticals position peaked at $167K in Q3 2021.
61 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2023, filed 8 May 2023.